1. Field of the Invention
The invention relates to an artificial airway device more specifically to a supraglottic airway designed to guide an esophageal blocker device into the esophagus and including a bite block.
2. Description of the Related Art
In general, supraglottic airways such as laryngeal masks allowing for both rapid lung ventilation and the insertion of medical instruments and tubes into the laryngeal openings of patients have been described in patents, such as U.S. Pat. No. 4,509,514 to Brain and U.S. Pat. Nos. 6,422,239 and 5,937,860 to Cook the entire disclosures of which were herein incorporated by reference. Laryngeal masks generally consist of two major components, a breathing tube and an inflatable mask, these devices are inserted into a patient's throat, and when properly positioned, cover the laryngeal opening. A seal is then formed around the circumference of the laryngeal opening by the inflation of a ring-like structure located toward the front of the mask (patient end). Inflation of the ring exerts pressure against the front, sides, and rear portions of the oropharynx, securing the device in place such that the laryngeal opening is positioned in alignment with a recessed cavity in the mask face. Extending from a point external to the oral cavity, the flexible breathing tube terminates within the recessed cavity, aligned axially with the laryngeal opening. The positioning of the flexible breathing tube allows the passage of endo-tracheal tubes or related medical instruments into the laryngeal opening, in addition to allowing for lung ventilation.
While current supraglottic airways such as laryngeal masks can provide for improved placement and breathing over a traditional endotracheal tube, they can still be improved. It has recently been recognized that it is desirable to both block off the patient's esophagus during use of the supraglottic airway to prevent stomach contents from interfering with the supraglottic airway and to prevent a patient's unintentional biting behavior from interfering with air passage in the supraglottic airway. Such blocking is not intended to inhibit movement of stomach contents during violent muscle contractions (such as while vomiting) but to inhibit more passive movement. Still further, it has been recognized that many patients who need a supraglottic airway have lost muscle control and can involuntarily bite down on the breathing tube which can result in it becoming obstructed and causing the patient discomfort and placing them in danger of potential suffocation.
Because of these and other problems in the art described herein is a supraglottic airway primarily intended to facilitate lung ventilation and the insertion of endo-tracheal tubes or related medical instruments into a patient's trachea as needed during general anesthesia, intensive care, critical patient care, or at any other time that ventilation would be desired. In a laryngeal mask embodiment of such a supraglottic airway, the mask comprises a flexible ventilation tube and an inflatable positioning shield generally conforming to the anatomy of the oropharynx region surrounding the laryngeal opening, and securely affixed to the distal end of the ventilation tube. The airway also includes an esophageal blocker and a guide structure for guiding the esophageal blocker into the esophagus, the blocker being deployed to block off the esophagus below the airway after the airway has been inserted. The airway additionally or alternatively includes a bite block designed to inhibit the patient from biting the breathing tube closed while the airway is in use.
There is described herein, among other things, a supraglottic airway and esophageal blocker in combination comprising; an esophageal blocker; a supraglottic airway including: a respiratory tube; means for creating an airtight seal in the oropharyngeal region of a patient; and a guide structure capable of guiding said esophageal blocker into an esophagus of said patient; wherein, when said airway is in said patient, said esophageal blocker can move relative to the airway and can be extended through said guide structure to then extend past a distal end of said airway into said esophagus of said patient.
In an embodiment of the combination the esophageal blocker is transported by said guide structure as said airway is placed in said patient. The guide structure may comprise a secondary tube which may be slotted.
In an embodiment, the respiratory tube is smoothly curved, the guide structure is mounted to said respiratory tube, and the airway includes a clip for holding said esophageal blocker in position relative said airway.
In an embodiment, the esophageal blocker includes an inflating and positioning tube and a balloon. The inflating and positioning tube may include markings to identify the location of said balloon relative said airway.
In a still further embodiment, the combination further comprises: a bite block formed onto said respiratory tube, wherein said bite block is sized and shaped to contact at least a portion of the teeth of a patient, when said airway is in said patient, if said patient attempts to bite down on said respiratory tube.
There is also described herein, a laryngeal mask and esophageal blocker in combination comprising; an esophageal blocker; a laryngeal mask including: a respiratory tube; a shield comprising an inflatable outer ring and a posterior base; and a guide structure capable of guiding said esophageal blocker into an esophagus of a patient; wherein, when said laryngeal mask is in said patient, said esophageal blocker can move relative to said mask and can be extended through said guide structure to then extend past a distal end of said shield into said esophagus of said patient.
In an embodiment of the combination the esophageal blocker is transported by said guide structure as said mask is placed in said patient. The guide structure may comprise a secondary tube which may be slotted.
In an embodiment of the combination the secondary tube is not directly connected to said shield. However, the secondary tube may direct a distal end of said esophageal blocker along said shield when said esophageal blocker is extended into said esophagus of said patient. The distal end of said esophageal blocker passing along a line of connection formed by the intersection of said posterior base and said outer ring and passing between said shield and said patient's oropharynx at said distal end of said shield.
In an embodiment, the respiratory tube is smoothly curved, the secondary tube twisting at least partially around said respiratory tube.
In an embodiment, the esophageal blocker includes an inflating and positioning tube and a balloon. The inflating and positioning tube may include markings to identify the location of said balloon relative said mask.
In an embodiment of the combination, the guide structure is mounted to said respiratory tube or said shield, and the airway includes a clip for holding said esophageal blocker in position relative said mask.
In a still further embodiment, the combination further comprises: a bite block formed onto said respiratory tube; wherein said bite block is sized and shaped to contact at least a portion of the teeth of a patient, when said laryngeal mask is in said patient, if said patient attempts to bite down on said respiratory tube.
There is also described herein, a laryngeal mask including an esophageal blocker, the mask comprising; a respiratory tube; a shield comprising an inflatable outer ring and a posterior base; esophageal blocking means for temporarily blocking off a patient's esophagus; and a guide means mounted to said respiratory tube for guiding said esophageal blocking means into said esophagus below a distal end of said shield. The esophageal blocking means may be transported by said guide means as said laryngeal mask is placed in said patient.
There is also described herein, a method for blocking a patient's esophagus while providing them with an artificial airway, the method comprising the steps of: providing a supraglottic airway capable of creating an airtight seal in the oropharyngeal region of a patient; providing an esophageal blocker; placing said supraglottic airway in a patient in the oropharyngeal region of said patient to provide the patient with an artificial airway; moving said esophageal blocker relative to said supraglottic airway in such a manner that a portion of said esophageal blocker is guided by the structure of said supraglottic airway past said supraglottic airway and into the esophagus of said patient, deploying said esophageal blocker in said esophagus to block said patient's esophagus.
There is also described herein, a laryngeal mask including a bite block, the mask comprising: a respiratory tube having a hollow passageway there through; a shield comprising an inflatable outer ring and a posterior base; and a bite block formed onto said respiratory tube; wherein said bite block is sized and shaped to contact at least one of: the cuspids, the bicuspids, or the molars of the patient, when said laryngeal mask is in said patient, if said patient attempts to bite down on said respiratory tube, said bite block preventing said bite from completely closing said hollow passageway.
In an embodiment of the mask, the respiratory tube is curved. In another embodiment of the mask the bite block is located on a side of said respiratory tube and a second bite block may be arranged on the opposing side of said respiratory tube.
The following detailed description illustrates by way of example and not by way of limitation. Described herein, among other things, is an embodiment of a supraglottic airway which is designed for use with an esophageal blocker. Specifically, the supraglottic airway includes structures which enable the airway to transport an esophageal blocker into the oropharynx area when the airway is inserted, and then facilitate the deployment of the esophageal blocker into the esophagus either during placement or once the airway is positioned. While the supraglottic airway described herein incorporates certain features for improved placement in the airway, it should be recognized that these features are not required for use of the esophageal blocker and the esophageal blocker and associated components attached to the airway can be used on any form of supraglottic airway.
The inflatable positioning shield (201) is composed of a generally wedge-shaped ellipsoid, ovoid, or toroid outer ring (401) with a pliable molded posterior base (403) attached thereto. The outer ring (401) is preferably repeatedly inflatable and deflatable with such inflation being accomplished by attachment of an inflation device (405) which is capable of pulling air from the ambient, into an inflation tube (407) and from there into the interior of the outer ring (401). The outer ring (401), when inflated, is sized and shaped to generally conform to the approximate available space in the oropharynx region.
The posterior base (403) is secured longitudinally within the hole in the center of the outer ring (401). The posterior base (403) is generally attached in a fashion to form an elongated and tapered hemisphere relative the generally major plane of the outer ring (401) so as to give the shield (201) the overall shape as seen in the FIGS. In the depicted embodiment, there are semi-rigid raised ridges (409) positioned longitudinally parallel to each other along the surface (413) of the posterior base (403) “inside” the hole of the outer ring (401).
The shield (201) is generally connected to the respiratory tube (205) by means of a hollow wedge (501) which allows the respiratory tube to pass through the shield (201) and into the recessed cavity (511) formed above the posterior base (403) and inside the hole in the outer ring (401).
The hollow wedge (501) is attached generally to the distal end (203) of the respiratory tube (205) which has passed through an airtight peripheral seal (505) towards the rear (503) of the inflatable positioning shield (201). The wedge (501) therefore gives an access into the shield recess (511) from the interior of the respiratory tube (205) allowing air to pass from the recessed cavity (511) into the distal end (203) of the respiratory tube (205) and from there out the proximal end (207) of the respiratory tube (205). The wedge (501) is generally formed into an angle (521) to the length of the respiratory tube (205) which is generally between 0 and 90 degrees and preferably about 30 to about 35 degrees with the posterior base (403), forming an elongated elliptically shaped distal lumen (523) open to the interior of the shield recess (511) and interior of the respiratory tube (205). The elongated lower surface of the wedge will generally comprise a reinforced support (525) which is affixed to the posterior base (403) possibly in a similarly sized recess (435) in said posterior base (403). The connection between the posterior base (403) and the reinforced support (525) may be formed in any manner known to one of ordinary skill in the art, however, in a preferred embodiment, the two devices are adhered together with a generally non-separable adhesive. In an alternative embodiment, they may be co-formed. The wedge (501) and respiratory tube (205) generally pass through the shield (201) in such a fashion as to form an airtight seal which inhibits air in the shield (201) from entering the respiratory tube (205) and vice-versa.
There may also be included a ventilation lumen (531) through the wedge (501) to provide an alternate airway in the event the distal lumen (523) becomes obstructed during patient lung ventilation. The ventilation lumen (531) also generally prevents the formation of a pressure differential between the shield recess (425) and flexible respiratory tube (205). Absent a pressure differential, any object obstructing the distal lumen (523) will not generally become inextricably lodged.
This general type of shield (201) is generally used on a number of different laryngeal masks (100) with modification of the shapes and sizes of various components. However, those of ordinary skill in the art will recognize that there is no need to include the shield (201) in other forms of supraglottic airway and that the seal to be generated with the pharynx can be generated in alternative fashions. In particular, other embodiments of airways can include alternative or additional structures for providing the airway. In other embodiments, the supraglottic airway, instead of providing a shield (201) may alternative provide another structure for creating a generally airtight seal in the oropharyngeal region of a patient, such as, but not limited to, an inflatable cuff, a solid structure sized and shaped to form such a seal with the oropharyngeal region by interaction with the throat, a structure capable of being held in place by positive or negative pressure, or any other structure or structures understood by one of ordinary skill in the art.
The respiratory tube (205) may be formed in any manner known to those of ordinary skill in the art but will generally form a smoothly curving hollow cylinder of generally circular or elliptical cross-section preferably approximating, for ease of insertion, the shape of the human throat. The respiratory tube (205) is preferably sized and shaped to accommodate the passage of endo-tracheal tubes and related medical devices up to 8.5 French in diameter. The length of respiratory tube (205) is such that when the laryngeal mask (100) is properly positioned for use within the oropharynx, the attachment (proximal) end (207) of respiratory tube (205) is located exterior to the oral cavity of the patient. The attachment end (207) of the respiratory tube (205) terminates in an unobstructed proximal lumen (209), providing a direct pathway through the respiratory tube (205) to the distal end (203) and distal lumen (523). In alternative embodiments, the attachment end (207) may be fitted with adapters or connectors (not shown) suitable for connection to a variety of medical devices, for example, lung ventilation machines.
There is also shown attached to the respiratory tube (205) a guide structure which in the depicted embodiment comprises a slotted secondary tube (101) which is placed externally to the respiratory tube (205) and runs generally along the outer surface (215) of the respiratory tube (205) in a curving pattern such as a partial helix. As can be seen in the FIGS, the secondary tube (101) is generally placed so as to have its proximal end (111) toward the proximal end (2.07) of the respiratory tube (205) and its distal end (113) toward the distal end (203) of the respiratory tube (205) prior to the airtight peripheral seal (505).
The secondary tube (101) is also preferably positioned so that its proximal end (111) is located on the side of the respiratory tube (205) relative to its curve as shown in the FIGS. This means the proximal end (111) of the secondary tube (101) is generally located at a point generally spaced at about its maximum from the plane which incorporates the curve of the respiratory tube (205) and that passes through the center of the respiratory tube (205). The secondary tube (101) then runs along the outside of the respiratory tube (205) generally twisting slightly about the outer surface (215) of the respiratory tube (205) so as to terminate at its distal end (113) at a point closer to the plane discussed above than the proximal end (111). That is, as shown in the
Generally, the distal end (113) of the secondary tube (101) is positioned below the major plane of the shield (201) but is on the respiratory tube (205) and spaced from the peripheral seal (403) so that its structure is connected only to the respiratory tube (205). However, in alternative embodiments the guide structure may be mounted on the respiratory tube (205), shield (201), both, or elsewhere on the laryngeal mask (100). One such embodiment where the guide structure is mounted on the shield (201) and respiratory tube (205) is shown in
It should be recognized that in alternative embodiments, it is not required for the guide structure to be a slotted tube as is depicted in
Supported by the guide structure is an esophageal blocker (801). In this case, the esophageal blocker (801) generally comprises an inflation and positioning tube (803) having a proximal (805) and distal (807) end and a length therebetween. Positioned toward or at the distal end (807) of the esophageal blocker (801) is a repeatedly inflatable and deflatable balloon (809) as is understood by those of ordinary skill in the art. In the depiction of
The inflation and positioning tube (803) will generally comprise a hollow tube having a maximum external diameter smaller than the minimum internal diameter of the secondary tube (101) so as to allow the esophageal blocker (801) to pass through the secondary tube (101). This passage may be facilitated by the inclusion of lubricants on the exterior surface of the esophageal blocker (801) as is known to those of ordinary skill in the art.
In the depicted embodiment, there is also included on the exterior surface (215) of the respiratory tube (205) a retainer clip (225) which is generally positioned above the proximal end (111) of the secondary tube (101) and is sized and shaped to frictionally or otherwise secure the inflation and positioning tube (803) of the esophageal blocker (801). This clip (225) is used to hold the esophageal blocker (801) in a selected position relative to the respiratory tube (205) during insertion and deployment.
In the depicted embodiment, there is also included on the exterior surface (215) of the respiratory tube (205), a bite block (901). The bite block (901) generally comprises a solid structure generally comprised of a plastic or other material with a relatively high compression resistance such as, but not limited to, hard rubber. The bite block (901) runs generally down the opposing side of the respiratory tube (205) to the secondary tube (101) and along a proximal portion of the length of the respiratory tube (205). The length and extension from the respiratory tube (205) is preferably selected so that when the laryngeal mask (100) is placed within a human patient, the bite block (901) does not pass into the throat but is within the oral cavity and possibly extends beyond the oral cavity outside the body.
The bite block (901) is generally designed so as to resist deformation of itself and the respiratory tube (205) in the event that the person who has had the laryngeal mask (100) installed in the orolaryngeal region was to involuntarily or voluntarily bite down on the respiratory tube (205). In particular, to be sufficiently resistant to deformation that the patient would generally be unable to generate sufficient force from the bite to compress the respiratory tube (205) sufficiently to close off the hollow passageway (206) therethrough and prevent air from passing through it. While the bite block (901) is not intended to prevent all deformation of the respiratory tube (205), the bite block (901) is intended to inhibit the biting action from closing off the internal passageway through the respiratory tube (205) completely.
To achieve this, the bite block (901) will generally stick out a sufficient distance from the exterior surface (215) of the respiratory tube (205) to be between the cuspids, bicuspids, or molars in the oral cavity of the person who has had the laryngeal mask (100) placed in their oropharyngeal region. In particular, using the ADA “Current Dental Terminology, 3rd edition (CDT-3) © 1999 Universal/National System of tooth numbering, the bite block will preferably contact at least one tooth of number 1 through 6, 10 through 22, or 28 through 32 in permanent dentition or of letter A through C, H through M, or R through T in primary dentition. In this way, their biting action is inhibited because the bite block (901) is located between the premolar's and molars on at least one side of the mouth. This makes it difficult for a biting action, to close the front teeth sufficiently to block the respiratory tube (205) when the bite block (901) is between these rearward teeth on either or both sides of the mouth. Even if significant force is placed on the bite block (901), the positioning of the bite block (901) between these teeth will generally prevent the front teeth from closing sufficiently to seal off the internal opening of the respiratory tube (205) as it leaves the mouth.
In this embodiment, the bite block (901) is generally hemispherical mirroring the size and shape of the respiratory tube (205). This shape both inhibits deformation and presents generally smooth surfaces to the interior of the mouth to inhibit injury from biting on the bite block (901) and to give a large surface for contact with the teeth.
While the embodiment of the laryngeal mask (100) in the FIGS shows both a bite block (901) and an esophageal blocker (801), one of ordinary skill would understand that in other embodiments a supraglottic airway could have only one or the other structure depending on the needs of the individual using it. In particular, in an embodiment, the supraglottic airway includes a bite block (901) but not a guide structure or esophageal blocker (801), and in another embodiment, the airway includes the guide structure and the esophageal blocker (801) but not the bite block (901). In a still further embodiment, a bite block (901) can be placed on both sides of the airway so as to provide for potentially easier placement and further inhibition on the effects of biting.
Generally, use of the laryngeal mask (100) would proceed as follows. The mask (100) is first placed in the ready position of
Positioned within the recessed cavity (511), the distal lumen (523) is axially aligned with the laryngeal opening, permitting positive lung ventilation to be performed, or allowing endo-tracheal tubes or related medical instruments inserted through the respiratory tube (205) to exit through the distal lumen (523) which is directly aligned for passage into the laryngeal opening. The bite block (901) is also aligned between the molars.
Once the laryngeal mask (100) is thus aligned, the user will unclip the inflation and positioning tube (803) of the esophageal blocker (801) from the clip (225) which will allow for movement of the esophageal blocker (801) relative to the mask (100). In an alternative embodiment, mask (100) does not carry the esophageal blocker (801) during insertion. Instead, the esophageal blocker (801) is inserted into the guide structure once the mask (100) is in place in the patient. In either case, the user will advance the distal end (807) of the esophageal blocker (801) toward the shield (201). Because of the inflation of the outer ring (401), there will generally be a roughly triangular cross-sectioned, funnel-shaped void formed at the line of connection (711) of the outer ring (401) and the posterior base (403) and the interaction of these devices with the rear of the patient's oropharynx. As the distal end (807) of the esophageal blocker (801) is extended, it is naturally directed into this void and runs generally along the intersection of the outer ring (401) and posterior base (403) as shown in
As should be apparent, the prior inflation or partial inflation of the outer ring (401) has pressed the material of the outer ring (401) in fairly tight contact with the throat. As the distal end (807) approaches the distal end (202) of the shield (201), the curvature of the line of connection (711) will begin to increase at a dramatic rate. Further, the outer ring (401) generally presents less pressure against the back of the throat here. The continued forward force on the esophageal blocker (801) from the user advancing it through the secondary tube (101) will result in the distal end (807) attempting to continue around the tightening curve, however the inherent stiffness of the inflation and positioning tube (803) will inhibit it bending at a sufficient curvature to continue to follow the line of connection (711) and the distal end (807) will eventually “jump” the line of connection (711) and pass between the outer ring (401) and the posterior pharynx toward the distal end (202) of the shield (201).
As should be apparent from
Once the distal end (807) of the esophageal blocker (801) has jumped the line of connection (711) and passed between the outer ring (401) and the posterior pharynx, the inflation and positioning tube (801) will then generally be advanced a certain additional distance beyond the distal end (202) of the shield (201) and into the proximal esophagus at which time the inflation and positioning tube (803) is re-secured to the clip (225) to hold the blocker (801) in the desired deployment position. The balloon (809) is then inflated in the esophagus producing the layout shown in
The blocking of the esophagus can be useful in the prevention of stomach gases or contents from coming up toward the laryngeal mask (100) and either interfering with its operation, causing damage, or injuring the patient. While it is not presumed that the esophageal blocker (801) will be sufficient to prevent the expelling of the mask (100) from a particularly strong muscle contraction (such as occurs when vomiting), it will generally prevent weaker movement of stomach contents (such as from acid reflux disease) from interfering with its operation.
In order to know the position of the esophageal blocker (801), the inflation and positioning tube (803) may have markings (851) thereon which generally correspond to the point at which the inflation and positioning tube (803) is to be clipped to the clip (225) to place the esophageal blocker (801) at both the ready position (
As should be apparent from the FIGS., as the esophageal blocker (801) generally runs along the back of the shield (201) when moving from the original ready position to the deployed position, and the shield (201) is preferably secured over the laryngeal opening at the time of esophageal blocker (801) deployment, it is very unlikely that the esophageal blocker (801) could enter the lungs. To do so, it would have to pass around the mask (100) or through the shield (201), both of which actions are very unlikely. Instead, it is simply and preferentially deployed into the esophagus. Further, the shield (201) being placed against the major nerves near the larynx, also serves to shield them from the passage of the esophageal blocker (801) further helping to inhibit injury to the patient.
Removal of the laryngeal mask (100) and blocker is normally the reverse of the insertion procedure described above although the esophageal blocker (801) may be totally removed from the patient and the guide structure prior to removal of the mask (100) instead of simply returning it to the ready position.
While the invention has been disclosed in connection with certain preferred embodiments, this should not be taken as a limitation to all of the provided details. Modifications and variations of the described embodiments may be made without departing from the spirit and scope of the invention, and other embodiments should be understood to be encompassed in the present disclosure as would be understood by those of ordinary skill in the art.
Number | Name | Date | Kind |
---|---|---|---|
678814 | Riggs | Jul 1901 | A |
1345425 | Wells | Jul 1920 | A |
2335741 | Contaldi | Nov 1943 | A |
2787010 | Uphoff | Apr 1957 | A |
3139088 | Galleher, Jr. | Jun 1964 | A |
3434100 | Dykzeul | Mar 1969 | A |
3606669 | Kemble | Sep 1971 | A |
3734100 | Walker et al. | May 1973 | A |
3756601 | Frey et al. | Sep 1973 | A |
3945069 | Cecil | Mar 1976 | A |
4146034 | Gupta | Mar 1979 | A |
4231365 | Scarberry | Nov 1980 | A |
4327720 | Bronson et al. | May 1982 | A |
4340046 | Cox | Jul 1982 | A |
4388076 | Waters | Jun 1983 | A |
4444201 | Itoh | Apr 1984 | A |
4509512 | LeClercq | Apr 1985 | A |
4509514 | Brain | Apr 1985 | A |
4520810 | Weiss | Jun 1985 | A |
RE31948 | Deutsch et al. | Jul 1985 | E |
4540959 | Saad | Sep 1985 | A |
4582056 | McCorkle, Jr. | Apr 1986 | A |
4593687 | Gray | Jun 1986 | A |
4661028 | Sanger | Apr 1987 | A |
4674496 | Svadijan et al. | Jun 1987 | A |
4751922 | DiPietropolo | Jun 1988 | A |
4791923 | Shapiro | Dec 1988 | A |
4825861 | Koss | May 1989 | A |
4863439 | Sanderson | Sep 1989 | A |
4872438 | Shah | Oct 1989 | A |
4895533 | Yagi | Jan 1990 | A |
4919127 | Pell | Apr 1990 | A |
4995388 | Brain | Feb 1991 | A |
5024220 | Holmgreen et al. | Jun 1991 | A |
5033919 | Choe | Jul 1991 | A |
5037251 | Roth | Aug 1991 | A |
5042475 | LaBombard | Aug 1991 | A |
5071413 | Utterberg | Dec 1991 | A |
5197463 | Jeshuran | Mar 1993 | A |
5218970 | Turnbull et al. | Jun 1993 | A |
5222487 | Carr et al. | Jun 1993 | A |
5241956 | Brain | Sep 1993 | A |
5253658 | King | Oct 1993 | A |
5277178 | Dingley | Jan 1994 | A |
5279610 | Park et al. | Jan 1994 | A |
5282464 | Brain | Feb 1994 | A |
5303697 | Brain | Apr 1994 | A |
5324080 | McNaughton et al. | Jun 1994 | A |
5326196 | Noll | Jul 1994 | A |
5340165 | Sheppard | Aug 1994 | A |
5355879 | Brain | Oct 1994 | A |
5391248 | Brain | Feb 1995 | A |
5392774 | Sato | Feb 1995 | A |
5393101 | Matkovich | Feb 1995 | A |
5477851 | Callaghan et al. | Dec 1995 | A |
5477852 | Landis et al. | Dec 1995 | A |
5509408 | Kurtis | Apr 1996 | A |
5513627 | Flam | May 1996 | A |
5520175 | Fry | May 1996 | A |
5527316 | Stone | Jun 1996 | A |
5529582 | Fukuhara | Jun 1996 | A |
5545048 | Maeda | Aug 1996 | A |
5546937 | Stuart et al. | Aug 1996 | A |
5562371 | Reed | Oct 1996 | A |
5562673 | Koblish et al. | Oct 1996 | A |
5569222 | Haselhorst et al. | Oct 1996 | A |
5579762 | Lee | Dec 1996 | A |
5584290 | Brain | Dec 1996 | A |
5588424 | Insler et al. | Dec 1996 | A |
5590643 | Flam | Jan 1997 | A |
5623921 | Kinsinger et al. | Apr 1997 | A |
5632271 | Brain | May 1997 | A |
RE35531 | Callaghan et al. | Jun 1997 | E |
5643174 | Yamamoto et al. | Jul 1997 | A |
5653231 | Bell | Aug 1997 | A |
5655519 | Alfery | Aug 1997 | A |
5682880 | Brain | Nov 1997 | A |
5711296 | Kolobow | Jan 1998 | A |
5713348 | Pell | Feb 1998 | A |
5720749 | Rupp | Feb 1998 | A |
5743258 | Sato | Apr 1998 | A |
5771889 | Pagan | Jun 1998 | A |
5772643 | Howell et al. | Jun 1998 | A |
5787879 | Gibson | Aug 1998 | A |
5791341 | Bullard | Aug 1998 | A |
5871012 | Neame et al. | Feb 1999 | A |
5878745 | Brain | Mar 1999 | A |
5881726 | Neame | Mar 1999 | A |
5896858 | Brain | Apr 1999 | A |
5937859 | Augustine et al. | Aug 1999 | A |
5937860 | Cook | Aug 1999 | A |
5947120 | Bailey | Sep 1999 | A |
5961489 | Hirota | Oct 1999 | A |
5979445 | Neame et al. | Nov 1999 | A |
5983897 | Pagan | Nov 1999 | A |
5988167 | Kamen | Nov 1999 | A |
6003514 | Pagan | Dec 1999 | A |
6012452 | Pagan | Jan 2000 | A |
6021779 | Pagan | Feb 2000 | A |
6050264 | Greenfield | Apr 2000 | A |
6086603 | Termin et al. | Jul 2000 | A |
6095144 | Pagan | Aug 2000 | A |
6110143 | Kamen | Aug 2000 | A |
6116243 | Pagan | Sep 2000 | A |
6119695 | Augustine et al. | Sep 2000 | A |
6196224 | Alfery | Mar 2001 | B1 |
6240922 | Pagan | Jun 2001 | B1 |
6261401 | Pagan | Jul 2001 | B1 |
6311688 | Augustine et al. | Nov 2001 | B1 |
6318367 | Mongeon | Nov 2001 | B1 |
6338343 | Augustine et al. | Jan 2002 | B1 |
6374827 | Bowden et al. | Apr 2002 | B1 |
6378521 | Van Den Berg | Apr 2002 | B1 |
6386199 | Alfery | May 2002 | B1 |
6390093 | Mongeon | May 2002 | B1 |
6422239 | Cook | Jul 2002 | B1 |
6427686 | Augustine et al. | Aug 2002 | B2 |
6443156 | Niklason et al. | Sep 2002 | B1 |
6450164 | Banner et al. | Sep 2002 | B1 |
6460540 | Klepper | Oct 2002 | B1 |
6604525 | Pagan | Aug 2003 | B2 |
6612305 | Fauza | Sep 2003 | B2 |
6631720 | Brain | Oct 2003 | B1 |
6634354 | Christopher | Oct 2003 | B2 |
6668821 | Christopher | Dec 2003 | B2 |
6698430 | Van Landuyt | Mar 2004 | B2 |
6705318 | Brain | Mar 2004 | B1 |
6705320 | Anderson | Mar 2004 | B1 |
6705321 | Cook | Mar 2004 | B2 |
6705322 | Chang | Mar 2004 | B2 |
6729325 | Alfery | May 2004 | B2 |
6761170 | Van Landuyt | Jul 2004 | B2 |
6799574 | Collins | Oct 2004 | B1 |
6830049 | Augustine et al. | Dec 2004 | B2 |
6892731 | Cook | May 2005 | B2 |
6895966 | Christopher | May 2005 | B2 |
6899147 | Ogawa et al. | May 2005 | B2 |
6923176 | Ranzinger | Aug 2005 | B2 |
6935153 | Frigo et al. | Aug 2005 | B2 |
6983744 | Alfery | Jan 2006 | B2 |
6986755 | Willy et al. | Jan 2006 | B2 |
7013899 | Alfery | Mar 2006 | B2 |
7021686 | Glasgow et al. | Apr 2006 | B2 |
7040312 | Alfery et al. | May 2006 | B2 |
7040322 | Fortuna | May 2006 | B2 |
7052456 | Simon | May 2006 | B2 |
7096868 | Tateo et al. | Aug 2006 | B2 |
7097802 | Brain | Aug 2006 | B2 |
7128071 | Brain | Oct 2006 | B2 |
20010050082 | Christopher | Dec 2001 | A1 |
20040020491 | Fortuna | Feb 2004 | A1 |
20040079364 | Christopher | Apr 2004 | A1 |
20050016529 | Cook | Jan 2005 | A1 |
20050051173 | Brain | Mar 2005 | A1 |
20050139220 | Christopher | Jun 2005 | A1 |
20060027238 | Lin | Feb 2006 | A1 |
20060076021 | Chang | Apr 2006 | A1 |
20060180156 | Baska | Aug 2006 | A1 |
20060207597 | Wright | Sep 2006 | A1 |
20070028923 | Souris et al. | Feb 2007 | A1 |
20070102001 | Brain | May 2007 | A1 |
20070137651 | Glassenberg et al. | Jun 2007 | A1 |
20070246050 | Parikh et al. | Oct 2007 | A1 |
20080078398 | Cook | Apr 2008 | A1 |
Number | Date | Country | |
---|---|---|---|
20080041392 A1 | Feb 2008 | US |